Establishment and validation of prognostic nomograms to predict the overall and cancer-specific survival in patients with hepatic malignant vascular tumors.

Zhangya Pu, Chen Jiang, Peng Fang, Zhiping Ruan, Yuanyuan Zhu, Xiaofang Wang, Yan Huang, Panpan Yi, Yayu Chen, Jun Quan, Zebing Huang, Zelong Liu, Xingwang HuPubMed 2022

TL;DR

This study addresses the challenge of predicting survival for rare hepatic malignant vascular tumors (HMVT) by developing and validating prognostic nomograms. These nomograms, built using a large population-based dataset, offer a more accurate way for clinicians to estimate a patient's 1-, 3-, and 5-year overall and cancer-specific survival.

What Problem Does This Paper Address?

Hepatic malignant vascular tumors (HMVT) are a group of rare cancers that arise from blood vessels in the liver. Unlike more common liver cancers like hepatocellular carcinoma, HMVT are poorly understood, making it difficult to predict patient outcomes and tailor treatment strategies. The rarity of these tumors means that large-scale studies characterizing their features and identifying prognostic factors have been scarce. This lack of understanding hinders the development of effective clinical management and personalized treatment approaches.

Methods

The researchers utilized a retrospective approach, analyzing data from the Surveillance, Epidemiology, and End Results (SEER) database, a comprehensive US cancer registry. They employed Kaplan-Meier survival analysis and Cox proportional hazard models to identify independent prognostic factors for overall survival (OS) and cancer-specific survival (CSS). Based on these identified factors, they constructed prognostic nomograms for the HMVT training cohort. The performance of these nomograms was then rigorously evaluated using concordance index (C-index), area under the curve (AUC) from time-dependent receiver operating characteristic (ROC) curves, and calibration curves in both the training and validation cohorts.

Datasets

The primary dataset used in this study was the Surveillance, Epidemiology, and End Results (SEER) database, specifically data from 1973 to 2015. This database provided information on 510 patients diagnosed with HMVT. The patients were randomly divided into a training cohort (N=308) and a validation cohort (N=202). No new datasets were introduced.

Key Insights and Ideas

  • Rarity is a Major Hurdle: The study highlights how the extreme rarity of HMVT makes it challenging to gather sufficient data for robust clinical research and to establish standardized treatment protocols.
  • Nomograms Offer a Path Forward: The development of validated prognostic nomograms provides a much-needed tool for clinicians to better stratify patients and predict their likely outcomes. This can inform treatment decisions and patient counseling.
  • Key Predictors Emerge: Several factors consistently emerged as significant predictors of survival across different HMVT subtypes and the overall cohort, including age, tumor grade, tumor size, and histological type.
  • Individualized Prognosis is Possible: The nomograms demonstrate that it's possible to create individualized survival predictions, moving beyond general statistics for these rare cancers.

Key Results

  • Large Cohort: This study represents the largest population-based analysis to date of clinicopathological characteristics in patients with HMVT.
  • Prognostic Factors Identified: Age at diagnosis, tumor grade, tumor size, and histological type were identified as significant prognostic factors for both OS and CSS. Sex was a predictor for CSS, and T stage for OS.
  • Nomogram Performance: The established nomograms for OS and CSS in the HMVT-training cohort showed credible performance with C-indices of 0.763 and 0.762, respectively.
  • AUC Values: AUC values for 1-, 3-, and 5-year OS were 0.873, 0.905, and 0.898, and for CSS were 0.808, 0.794, and 0.788, respectively, indicating good predictive accuracy.
  • Validation Success: Calibration curves demonstrated favorable agreement between predicted and actual survival rates in both training and validation cohorts, confirming the nomograms' reliability.

Limitations and Future Work

The authors acknowledge several limitations:

  • Limited Treatment Data: The SEER database has a low proportion of patients with detailed treatment information, which restricted the precise analysis of treatment's impact on prognosis.
  • Qualitative/Semi-quantitative Data: The SEER database contains qualitative or semi-quantitative data, which can introduce some statistical limitations.
  • Retrospective Nature: As with all retrospective studies, biases are inevitably introduced.

Future work could focus on:

  • Further Research on Treatments: More in-depth research is needed to precisely elaborate the role of various treatments in predicting survival probability, especially given the limited treatment data in the current study.
  • Prospective Studies: While challenging due to rarity, prospective studies would be valuable to further validate these findings and refine the nomograms.
  • Exploring Specific Subtypes: While the study provides an overall HMVT nomogram, further research into developing specific nomograms for individual HMVT subtypes (like AS and EHE, for which preliminary nomograms were developed) could offer even more tailored predictions.

Summary updated

Abstract

This was the largest population-based study to describe the clinicopathologic characteristics in patients with HMVT. Moreover, we established and validated prognostic nomograms that indicated an accurate prediction for 1-, 3- and 5-year of OS and CSS.
BibTeX
@inproceedings{pu2022establishment,
  author = {Zhangya Pu and Chen Jiang and Peng Fang and Zhiping Ruan and Yuanyuan Zhu and Xiaofang Wang and Yan Huang and Panpan Yi and Yayu Chen and Jun Quan and Zebing Huang and Zelong Liu and Xingwang Hu},
  title = {{Establishment and validation of prognostic nomograms to predict the overall and cancer-specific survival in patients with hepatic malignant vascular tumors.}},
  booktitle = {PubMed},
  year = {2022},
}
Figure